Bausch Health Co. Inc. (NYSE: BHC) reported Q2 EPS of ($0.92), may not compare to the analyst estimate of $0.66. Revenue for the quarter came in at $1.66 billion versus the consensus estimate of $1.79 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2020 revenue of $7.8-8 billion, versus the consensus of $8.05 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.